SAN FRANCISCO, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors with losses over $50,000 of the January 8, 2016 lead plaintiff deadline in the securities fraud class action lawsuit filed against Starz (NASDAQ:STRZA) (NASDAQ:STRZB).
If you purchased Starz securities between August 1, 2014 and October 29, 2015, contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation, by calling (510) 725-3000, emailing [email protected] or visiting http://www.hbsslaw.com/cases/strza. The lawsuit was filed in the U.S. District Court for the Central District of California and investors have until January 8, 2016 to move the court to act as lead plaintiff.
On October 29, 2015, Deadline Hollywood revealed that a lawsuit had been filed against Starz, CEO Christopher Albrecht, CRO Michael Thornton, and Liberty Media by the Company’s former Senior Vice President of Sales and Affiliate Marketing, Keno Thomas; the Thomas complaint alleges that defendants retaliated against Mr. Thomas for whistleblowing with regard to the Company’s affiliate carriage deals with Comcast and DirecTV and for refusing to participate in illegal behavior. When this news entered the market, Starz share price declined and injured investors.
The complaint alleges that Starz misled its investors and failed to disclose that (1) Starz lacked adequate internal controls; (2) according to a former Starz senior executive, Starz’s contract with Comcast Corporation was a result of illicit business practices; and (3) as a result, Starz’s public statements were materially false and misleading at all relevant times.
If you lost more than $50,000 in your investments in Starz securities and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.
Whistleblowers: Persons with non-public information regarding Starz should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at (510) 725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter at http://www.hbsslaw.com/hagens-berman-investor-fraud-center/securitites-newsletter, and visit the blog at www.meaningfuldisclosure.com. For the latest news visit http://www.hbsslaw.com/cases/pressreleases or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, (510) 725-3000


Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 



